☰

Michael Evangelopoulos - Publications

Affiliations: 
2018- Northwestern University, Evanston, IL 
Tree Info Similar researchers PubMed Report error

13/48 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Park J, Evangelopoulos M, Vasher MK, Kudruk S, Ramani N, Mayer V, Solivan AC, Lee A, Mirkin CA. Enhancing Endosomal Escape and Gene Regulation Activity for Spherical Nucleic Acids. Small (Weinheim An Der Bergstrasse, Germany). e2306902. PMID 37932003 DOI: 10.1002/smll.202306902  0.742
2023 Dittmar JW, Teplensky MH, Evangelopoulos M, Qin L, Zhang B, Mirkin CA. Tuning DNA Dissociation from Spherical Nucleic Acids for Enhanced Immunostimulation. Acs Nano. 17: 17996-18007. PMID 37713675 DOI: 10.1021/acsnano.3c04333  0.796
2023 Vasher MK, Evangelopoulos M, Mirkin CA. Transforming Hairpin-like siRNA-Based Spherical Nucleic Acids into Biocompatible Constructs. Acs Applied Bio Materials. PMID 37567247 DOI: 10.1021/acsabm.3c00574  0.764
2023 Teplensky MH, Evangelopoulos M, Dittmar JW, Forsyth CM, Sinegra AJ, Wang S, Mirkin CA. Multi-antigen spherical nucleic acid cancer vaccines. Nature Biomedical Engineering. PMID 36717738 DOI: 10.1038/s41551-022-01000-2  0.701
2023 Distler ME, Cavaliere JP, Teplensky MH, Evangelopoulos M, Mirkin CA. Molecular DNA dendron vaccines. Proceedings of the National Academy of Sciences of the United States of America. 120: e2215091120. PMID 36696444 DOI: 10.1073/pnas.2215091120  0.823
2022 Huang C, Han Z, Evangelopoulos M, Mirkin CA. CRISPR Spherical Nucleic Acids. Journal of the American Chemical Society. PMID 36201634 DOI: 10.1021/jacs.2c07913  0.441
2022 Huang Z, Callmann CE, Wang S, Vasher MK, Evangelopoulos M, Petrosko SH, Mirkin CA. Rational Vaccinology: Harnessing Nanoscale Chemical Design for Cancer Immunotherapy. Acs Central Science. 8: 692-704. PMID 35756370 DOI: 10.1021/acscentsci.2c00227  0.736
2022 Teplensky MH, Distler ME, Kusmierz CD, Evangelopoulos M, Gula H, Elli D, Tomatsidou A, Nicolaescu V, Gelarden I, Yeldandi A, Batlle D, Missiakas D, Mirkin CA. Spherical nucleic acids as an infectious disease vaccine platform. Proceedings of the National Academy of Sciences of the United States of America. 119: e2119093119. PMID 35312341 DOI: 10.1073/pnas.2119093119  0.754
2021 Teplensky MH, Dittmar JW, Qin L, Wang S, Evangelopoulos M, Zhang B, Mirkin CA. Spherical Nucleic Acid Vaccine Structure Markedly Influences Adaptive Immune Responses of Clinically Utilized Prostate Cancer Targets. Advanced Healthcare Materials. e2101262. PMID 34494382 DOI: 10.1002/adhm.202101262  0.783
2021 Distler ME, Teplensky MH, Bujold KE, Kusmierz CD, Evangelopoulos M, Mirkin CA. DNA Dendrons as Agents for Intracellular Delivery. Journal of the American Chemical Society. 143: 13513-13518. PMID 34410116 DOI: 10.1021/jacs.1c07240  0.727
2021 Sinegra AJ, Evangelopoulos M, Park J, Huang Z, Mirkin CA. Lipid Nanoparticle Spherical Nucleic Acids for Intracellular DNA and RNA Delivery. Nano Letters. PMID 34286581 DOI: 10.1021/acs.nanolett.1c01973  0.733
2020 Sushnitha M, Evangelopoulos M, Tasciotti E, Taraballi F. Cell Membrane-Based Biomimetic Nanoparticles and the Immune System: Immunomodulatory Interactions to Therapeutic Applications. Frontiers in Bioengineering and Biotechnology. 8: 627. PMID 32626700 DOI: 10.3389/fbioe.2020.00627  0.306
2018 Arrighetti N, Corbo C, Evangelopoulos M, Pasto A, Zuco V, Tasciotti E. Exosome-like nanovectors for drug delivery in cancer. Current Medicinal Chemistry. PMID 30182846 DOI: 10.2174/0929867325666180831150259  0.304
Low-probability matches (unlikely to be authored by this person)
2019 Pasto A, Giordano F, Evangelopoulos M, Amadori A, Tasciotti E. Cell membrane protein functionalization of nanoparticles as a new tumor-targeting strategy. Clinical and Translational Medicine. 8: 8. PMID 30877412 DOI: 10.1186/s40169-019-0224-y  0.291
2013 Parodi A, Quattrocchi N, van de Ven AL, Chiappini C, Evangelopoulos M, Martinez JO, Brown BS, Khaled SZ, Yazdi IK, Enzo MV, Isenhart L, Ferrari M, Tasciotti E. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nature Nanotechnology. 8: 61-8. PMID 23241654 DOI: 10.1038/Nnano.2012.212  0.281
2018 Martinez JO, Molinaro R, Hartman KA, Boada C, Sukhovershin R, De Rosa E, Kirui D, Zhang S, Evangelopoulos M, Carter AM, Bibb JA, Cooke JP, Tasciotti E. Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery. Theranostics. 8: 1131-1145. PMID 29464004 DOI: 10.7150/thno.22078  0.255
2021 De Vita A, Liverani C, Molinaro R, Martinez JO, Hartman KA, Spadazzi C, Miserocchi G, Taraballi F, Evangelopoulos M, Pieri F, Bongiovanni A, Mercatali L, Tasciotti E, Ibrahim T. Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer. Scientific Reports. 11: 5107. PMID 33658580 DOI: 10.1038/s41598-021-84492-3  0.252
2017 Molinaro R, Corbo C, Livingston M, Evangelopoulos M, Parodi A, Boada C, Agostini M, Tasciotti E. Inflammation and Cancer: In Medio Stat Nano. Current Medicinal Chemistry. PMID 28933296 DOI: 10.2174/0929867324666170920160030  0.246
2017 Näkki S, Martinez J, Evangelopoulos M, Xu W, Lehto VP, Tasciotti E. Chlorin e6 Functionalized Theranostic Multistage Nanovectors Transported by Stem Cells for Effective Photodynamic Therapy. Acs Applied Materials & Interfaces. PMID 28640590 DOI: 10.1021/acsami.7b05766  0.246
2018 Evangelopoulos M, Parodi A, Martinez JO, Tasciotti E. Trends towards Biomimicry in Theranostics. Nanomaterials (Basel, Switzerland). 8. PMID 30134564 DOI: 10.3390/nano8090637  0.244
2016 Palomba R, Parodi A, Evangelopoulos M, Acciardo S, Corbo C, de Rosa E, Yazdi IK, Scaria S, Molinaro R, Furman NE, You J, Ferrari M, Salvatore F, Tasciotti E. Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability. Scientific Reports. 6: 34422. PMID 27703233 DOI: 10.1038/Srep34422  0.242
2015 Evangelopoulos M, Parodi A, Martinez JO, Yazdi IK, Cevenini A, van de Ven AL, Quattrocchi N, Boada C, Taghipour N, Corbo C, Brown BS, Scaria S, Liu X, Ferrari M, Tasciotti E. Cell source determines the immunological impact of biomimetic nanoparticles. Biomaterials. 82: 168-177. PMID 26761780 DOI: 10.1016/J.Biomaterials.2015.11.054  0.235
2015 Corbo C, Parodi A, Evangelopoulos M, Engler DA, Matsunami RK, Engler AC, Molinaro R, Scaria S, Salvatore F, Tasciotti E. Proteomic Profiling of a Biomimetic Drug Delivery Platform. Current Drug Targets. 16: 1540-7. PMID 25382209  0.235
2017 Parodi A, Molinaro R, Sushnitha M, Evangelopoulos M, Martinez JO, Arrighetti N, Corbo C, Tasciotti E. Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery. Biomaterials. 147: 155-168. PMID 28946131 DOI: 10.1016/j.biomaterials.2017.09.020  0.235
2012 Martinez JO, Brown BS, Quattrocchi N, Evangelopoulos M, Ferrari M, Tasciotti E. Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications. Chinese Science Bulletin = Kexue Tongbao. 57: 3961-3971. PMID 24587616 DOI: 10.1007/S11434-012-5387-5  0.232
2020 Evangelopoulos M, Yazdi IK, Acciardo S, Palomba R, Giordano F, Pasto A, Sushnitha M, Martinez JO, Basu N, Torres A, Hmaidan S, Parodi A, Tasciotti E. Biomimetic cellular vectors for enhancing drug delivery to the lungs. Scientific Reports. 10: 172. PMID 31932600 DOI: 10.1038/s41598-019-55909-x  0.23
2017 Balasubramanian K, Evangelopoulos M, Brown BS, Parodi A, Celia C, Yazdi IK, Tasciotti E. Ghee Butter as a Therapeutic Delivery System. Journal of Nanoscience and Nanotechnology. 17: 977-82. PMID 29671486  0.23
2016 Molinaro R, Corbo C, Martinez JO, Taraballi F, Evangelopoulos M, Minardi S, Yazdi IK, Zhao P, De Rosa E, Sherman MB, De Vita A, Toledano Furman NE, Wang X, Parodi A, Tasciotti E. Biomimetic proteolipid vesicles for targeting inflamed tissues. Nature Materials. PMID 27213956 DOI: 10.1038/Nmat4644  0.229
2014 Martinez JO, Evangelopoulos M, Karun V, Shegog E, Wang JA, Boada C, Liu X, Ferrari M, Tasciotti E. The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulation. Biomaterials. 35: 9824-32. PMID 25176066 DOI: 10.1016/J.Biomaterials.2014.08.024  0.228
2016 Khaled SZ, Cevenini A, Yazdi IK, Parodi A, Evangelopoulos M, Corbo C, Scaria S, Hu Y, Haddix SG, Corradetti B, Salvatore F, Tasciotti E. One-pot synthesis of pH-responsive hybrid nanogel particles for the intracellular delivery of small interfering RNA. Biomaterials. 87: 57-68. PMID 26901429 DOI: 10.1016/J.Biomaterials.2016.01.052  0.225
2018 Molinaro R, Evangelopoulos M, Hoffman JR, Corbo C, Taraballi F, Martinez JO, Hartman KA, Cosco D, Costa G, Romeo I, Sherman M, Paolino D, Alcaro S, Tasciotti E. Design and Development of Biomimetic Nanovesicles Using a Microfluidic Approach. Advanced Materials (Deerfield Beach, Fla.). PMID 29512198 DOI: 10.1002/adma.201702749  0.225
2020 Zinger A, Brozovich A, Pasto A, Sushnitha M, Martinez JO, Evangelopoulos M, Boada C, Tasciotti E, Taraballi F. Bioinspired Extracellular Vesicles: Lessons Learned From Nature for Biomedicine and Bioengineering. Nanomaterials (Basel, Switzerland). 10. PMID 33143238 DOI: 10.3390/nano10112172  0.224
2021 Boada CA, Zinger A, Rohen S, Martinez JO, Evangelopoulos M, Molinaro R, Lu M, Villarreal-Leal RA, Giordano F, Sushnitha M, De Rosa E, Simonsen JB, Shevkoplyas S, Taraballi F, Tasciotti E. LDL-Based Lipid Nanoparticle Derived for Blood Plasma Accumulates Preferentially in Atherosclerotic Plaque. Frontiers in Bioengineering and Biotechnology. 9: 794676. PMID 34926432 DOI: 10.3389/fbioe.2021.794676  0.222
2020 Parodi A, Evangelopoulos M, Arrighetti N, Cevenini A, Livingston M, Khaled SZ, Brown BS, Yazdi IK, Paradiso F, Campa-Carranza JN, De Vita A, Taraballi F, Tasciotti E. Endosomal Escape of Polymer-Coated Silica Nanoparticles in Endothelial Cells. Small (Weinheim An Der Bergstrasse, Germany). e1907693. PMID 32643290 DOI: 10.1002/smll.201907693  0.22
2014 Martinez JO, Evangelopoulos M, Bhavane R, Acciardo S, Salvatore F, Liu X, Ferrari M, Tasciotti E. Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs. Current Drug Targets. PMID 25316273 DOI: 10.2174/1389450115666141015113914  0.211
2015 Scavo MP, Gentile E, Wolfram J, Gu J, Barone M, Evangelopoulos M, Martinez JO, Liu X, Celia C, Tasciotti E, Vilar E, Shen H. Multistage vector delivery of sulindac and silymarin for prevention of colon cancer. Colloids and Surfaces. B, Biointerfaces. 136: 694-703. PMID 26513752 DOI: 10.1016/j.colsurfb.2015.10.005  0.196
2017 Corradetti B, Taraballi F, Martinez JO, Minardi S, Basu N, Bauza G, Evangelopoulos M, Powell S, Corbo C, Tasciotti E. Hyaluronic acid coatings as a simple and efficient approach to improve MSC homing toward the site of inflammation. Scientific Reports. 7: 7991. PMID 28801676 DOI: 10.1038/s41598-017-08687-3  0.187
2013 Martinez JO, Boada C, Yazdi IK, Evangelopoulos M, Brown BS, Liu X, Ferrari M, Tasciotti E. Short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors. Small (Weinheim An Der Bergstrasse, Germany). 9: 1722-33. PMID 23255523 DOI: 10.1002/Smll.201201939  0.161
2018 Tsao C, Pandolfi L, Wang X, Minardi S, Lupo C, Evangelopoulos M, Hendrickson T, Shi A, Storci G, Taraballi F, Tasciotti E. Electrospun Patch Functionalized with Nanoparticles Allows for Spatiotemporal Release of VEGF and PDGF-BB Promoting In Vivo Neovascularization. Acs Applied Materials & Interfaces. PMID 30511828 DOI: 10.1021/acsami.8b19975  0.158
2014 Martinez JO, Evangelopoulos M, Chiappini C, Liu X, Ferrari M, Tasciotti E. Degradation and biocompatibility of multistage nanovectors in physiological systems. Journal of Biomedical Materials Research. Part A. 102: 3540-9. PMID 25269799 DOI: 10.1002/Jbm.A.35017  0.15
2020 García-Salinas S, Evangelopoulos M, Gámez-Herrera E, Arruebo M, Irusta S, Taraballi F, Mendoza G, Tasciotti E. Electrospun anti-inflammatory patch loaded with essential oils for wound healing. International Journal of Pharmaceutics. 119067. PMID 31981705 DOI: 10.1016/j.ijpharm.2020.119067  0.128
2015 Yazdi IK, Ziemys A, Evangelopoulos M, Martinez JO, Kojic M, Tasciotti E. Physicochemical properties affect the synthesis, controlled delivery, degradation and pharmacokinetics of inorganic nanoporous materials. Nanomedicine (London, England). PMID 26419750 DOI: 10.2217/nnm.15.133  0.126
2017 Evangelopoulos M, Tasciotti E. Bioinspired approaches for cancer nanotheranostics. Nanomedicine (London, England). 12: 5-7. PMID 27876435 DOI: 10.2217/nnm-2016-0374  0.122
2014 Fernandez-Moure JS, Evangelopoulos M, Scaria S, Martinez JO, Brown BS, Coronel AC, Chan P, Weiner B, Ferrari M, Tasciotti E. Multistage porous silicon for cancer therapy Porous Silicon For Biomedical Applications. 374-402. DOI: 10.1533/9780857097156.3.374  0.104
2016 Tasciotti E, Cabrera FJ, Evangelopoulos M, Martinez JO, Thekkedath UR, Kloc M, Ghobrial RM, Li XC, Grattoni A, Ferrari M. The Emerging Role of Nanotechnology in Cell and Organ Transplantation. Transplantation. PMID 27257995 DOI: 10.1097/Tp.0000000000001100  0.1
2017 Fernandez-Moure JS, Evangelopoulos M, Colvill K, Van Eps JL, Tasciotti E. Nanoantibiotics: a new paradigm for the treatment of surgical infection. Nanomedicine (London, England). 12: 1319-1334. PMID 28520517 DOI: 10.2217/nnm-2017-0401  0.074
2013 Martinez JO, Boada C, Yazdi IK, Evangelopoulos M, Brown BS, Liu X, Ferrari M, Tasciotti E. Mesoporous Silicon: Short and Long Term, In Vitro and In Vivo Correlations of Cellular and Tissue Responses to Mesoporous Silicon Nanovectors (Small 9-10/2013) Small. 9: 1721-1721. DOI: 10.1002/Smll.201370058  0.068
2023 Palomba R, Schlich M, Evangelopoulos M, Spanò R. Editorial: Novel approaches aiming to overcome current nanomedicine limitations. Frontiers in Molecular Biosciences. 10: 1247959. PMID 37475888 DOI: 10.3389/fmolb.2023.1247959  0.044
Hide low-probability matches.